The global central venous catheter market is on a strong upward trajectory, with projections indicating a rise from USD 2,861.0 million in 2024 to a remarkable USD 5,436.8 million by 2034. This growth ...

For use in clearing occlusions of venous-access devices ... and 2 mg to clear clots in central venous catheters pending the results of a study to determine the effectiveness of smaller doses.

Healthcare systems face challenges in meeting the growing demand for dialysis services due to critical gaps and shortcomings.

Eligible oncology patients can receive their oral cancer medications at home while being treated for other medical needs ...

A study in patients with solid tumors found that CRBSI is significantly linked to mortality in patients with PICCs, whereas CRT and CRLC are not significant risk factors.

Doctors and scientists are eyeing Canada as a place to work because of the current American situation. In the United States, ...

Anaconda Biomed, SL, announced the publication of results of the ANAIS study, which evaluated the safety and performance of the c ...

The catheters are inserted several times a day, once the bladder is drained it is removed. People with bladder control issues or other medical conditions, such as bladder dysfunction, neurologic ...

The Milwaukee Bucks announced in late March that star guard Damian Lillard has deep vein thrombosis in his right calf — a little more than a month after San Antonio Spurs star Victor Wembanyama ...

The FDA has accepted for Priority Review the sBLA for aflibercept injection 8mg for the treatment of macular edema following RVO and for monthly dosing in approved indications.

ii Prevent venous thromboembolism. Eliminate hospital-acquired venous ... patient rooms and bathrooms and creating decentralized nurses' stations that allow easy access to patients. Reduce infections ...